Henan Newland Pharmaceutical Co.,Ltd.’s Net Profit Rose 37.1% in First Quarter of 2023

Henan Newland Pharmaceutical Co.,Ltd. (河南新天地药业股份有限公司) (301277.SZ) reported a net profit of 46.5 million yuan in the first quarter of 2023, up 37.1% year-on-year.

Meanwhile, the company posted 172.5 million yuan in revenue, up 7.5% year-on-year.

At the end of the reporting period, it had 1.6 billion yuan in total assets and 204.7 million yuan in total liabilities, with a liability-to-asset ratio of 12.7%.